Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway

This publication has 41 references indexed in Scilit:

• Islet β cell mass in diabetes and how it relates to function, birth, and death
  Annals of the New York Academy of Sciences, 2013
• Significant Human β-Cell Turnover Is Limited to the First Three Decades of Life as Determined byin VivoThymidine Analog Incorporation and Radiocarbon Dating
  The Journal of Clinical Endocrinology & Metabolism, 2010
• Expansion of β-cell mass in response to pregnancy
  Trends in Endocrinology & Metabolism, 2010
• The Transcriptional Response of the Islet to Pregnancy in Mice
  Molecular Endocrinology, 2009
• Minireview: Meeting the Demand for Insulin: Molecular Mechanisms of Adaptive Postnatal ß-Cell Mass Expansion
  Molecular Endocrinology, 2009
• Glycogen Synthase Kinase-3 and Mammalian Target of Rapamycin Pathways Contribute to DNA Synthesis, Cell Cycle Progression, and Proliferation in Human Islets
  Diabetes, 2009
• Detailed transcriptome atlas of the pancreatic beta cell
  BMC Medical Genomics, 2009
• Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
  Endocrine Reviews, 2007
• Proliferation of sorted human and rat beta cells
  Diabetologia, 2007
• Increased Pancreatic β-Cell Proliferation Mediated by CREB Binding Protein Gene Activation
  Molecular and Cellular Biology, 2006